[go: up one dir, main page]

DE69532968T2 - Verfahren zur sekretion thrombopoitin polypeptide - Google Patents

Verfahren zur sekretion thrombopoitin polypeptide Download PDF

Info

Publication number
DE69532968T2
DE69532968T2 DE69532968T DE69532968T DE69532968T2 DE 69532968 T2 DE69532968 T2 DE 69532968T2 DE 69532968 T DE69532968 T DE 69532968T DE 69532968 T DE69532968 T DE 69532968T DE 69532968 T2 DE69532968 T2 DE 69532968T2
Authority
DE
Germany
Prior art keywords
dna constructs
dna
thrombopoietin
polypeptide
secretory peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69532968T
Other languages
English (en)
Other versions
DE69532968D1 (de
Inventor
C Foster
D Heipel
D Holly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DE69532968D1 publication Critical patent/DE69532968D1/de
Publication of DE69532968T2 publication Critical patent/DE69532968T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/524—Thrombopoietin, i.e. C-MPL ligand
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69532968T 1994-11-30 1995-11-15 Verfahren zur sekretion thrombopoitin polypeptide Expired - Fee Related DE69532968T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/347,029 US5641655A (en) 1994-11-30 1994-11-30 Methods for producing thrombopoietin polypeptides using a mammalian tissue plasminogen activator secretory peptide
PCT/US1995/014932 WO1996017067A1 (en) 1994-11-30 1995-11-15 Method for secreting thrombopoietin polypeptides

Publications (2)

Publication Number Publication Date
DE69532968D1 DE69532968D1 (de) 2004-06-03
DE69532968T2 true DE69532968T2 (de) 2004-10-21

Family

ID=23362032

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69532968T Expired - Fee Related DE69532968T2 (de) 1994-11-30 1995-11-15 Verfahren zur sekretion thrombopoitin polypeptide

Country Status (11)

Country Link
US (1) US5641655A (de)
EP (1) EP0799317B8 (de)
JP (1) JP2002514887A (de)
KR (1) KR100320106B1 (de)
CN (1) CN1171819A (de)
AT (1) ATE265538T1 (de)
AU (1) AU689373B2 (de)
CA (1) CA2206399C (de)
DE (1) DE69532968T2 (de)
NZ (1) NZ301858A (de)
WO (1) WO1996017067A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8357513B1 (en) 1994-01-03 2013-01-22 Genentech, Inc. Nucleic acids encoding mpl ligand (thrombopoietin) and fragments thereof
US5641665A (en) * 1994-11-28 1997-06-24 Vical Incorporated Plasmids suitable for IL-2 expression
PL188795B1 (pl) 1995-06-07 2005-04-29 Glaxo Group Ltd Związek wiążący się z receptorem trombopoetyny, kompozycja farmaceutyczna i zastosowanie związku wiążącego się z receptorem trombopoetyny
US5869451A (en) * 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6251864B1 (en) 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
US6884419B1 (en) 1996-12-23 2005-04-26 Kyowa Hakko Kogyo, Co., Ltd. hG-CSF fusion polypeptide having c-mpl activity, DNA coding for same and methods of treating anemia using same
CA2325022A1 (en) * 1998-04-16 1999-10-21 Genentech, Inc. Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence
KR19990081421A (ko) * 1998-04-29 1999-11-15 성재갑 동물세포를 이용한 인간 혈소판 생성 촉진인자(tpo)의 제조방법
US6770479B1 (en) 1998-07-10 2004-08-03 The United States Of America As Represented By The Secretary Of The Army Anthrax vaccine
CA2339355A1 (en) * 1998-07-10 2000-01-20 U.S. Medical Research Institute Of Infectious Diseases Anthrax vaccine
WO2000024770A2 (en) * 1998-10-23 2000-05-04 Amgen Inc. Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
WO2000034474A2 (en) 1998-12-07 2000-06-15 Zymogenetics, Inc. Growth factor homolog zvegf3
AU6069800A (en) 1999-07-07 2001-01-30 Zymogenetics Inc. Human cytokine receptor
EP2132984A3 (de) 2000-06-30 2010-11-03 ZymoGenetics, L.L.C. Interferonähnliches Protein ZCYTO21
US6673580B2 (en) * 2000-10-27 2004-01-06 Genentech, Inc. Identification and modification of immunodominant epitopes in polypeptides
ES2322945T5 (es) * 2001-12-21 2012-10-17 Immunex Corporation Métodos para purficación de proteína
US20040028661A1 (en) * 2002-08-07 2004-02-12 Bartelmez Stephen H. Expansion of cells using thrombopoietin and anti-transforming growth factor-beta
ES2462916T3 (es) 2002-09-18 2014-05-26 Janssen Pharmaceuticals, Inc. Métodos para aumentar la producción de células madre hematopoyéticas y plaquetas
CN1910200A (zh) 2003-08-07 2007-02-07 津莫吉尼蒂克斯公司 Il－28和il－29的均一化制剂
ME00313B (me) 2003-08-28 2011-05-10 Ortho Mcneil Pharm Inc Peptidi i jedinjenja koja se vežu za receptor
CA2558811A1 (en) 2004-03-08 2005-09-22 Zymogenetics, Inc. Dimeric fusion proteins and materials and methods for producing them
CN101829318B (zh) 2004-07-29 2012-07-04 津莫吉尼蒂克斯有限责任公司 Il-28和il-29治疗癌症和自身免疫性疾病的用途
JP2008532931A (ja) 2005-02-08 2008-08-21 ザイモジェネティクス， インコーポレイテッド 抗ｉｌ−２０、抗ｉｌ−２２および抗ｉｌ−２２ｒａ抗体ならびに結合パートナー、ならびに炎症における使用法
WO2006124667A2 (en) 2005-05-12 2006-11-23 Zymogenetics, Inc. Compositions and methods for modulating immune responses
US20120003241A1 (en) * 2007-08-09 2012-01-05 University Of Rochester Vaccine against botulism
US7858759B2 (en) 2007-10-04 2010-12-28 Zymogenetics, Inc. Anti-zB7H6 antibody-drug conjugates
DK2225267T3 (en) 2007-11-21 2015-04-27 Roskilde Uni Polypeptides comprising a isbindende activity
WO2009092806A2 (en) * 2008-01-25 2009-07-30 Aarhus Universitet Selective exosite inhibition of papp-a activity against igfbp-4
HRP20140244T1 (hr) 2008-03-27 2014-04-11 Zymogenetics, Inc. Sastavi i metode za inhibiranje pdgfrbeta i vegf-a
EP2623112B1 (de) 2008-06-27 2015-03-04 Zymogenetics, Inc. Lösliche hybride FC-Gamma-Rezeptoren und zugehörige Verfahren
JP2013531982A (ja) 2010-06-09 2013-08-15 ザイモジェネティクス， インコーポレイテッド 二量体ｖｓｔｍ３融合タンパク質および関連組成物および方法
US9175281B2 (en) * 2010-11-16 2015-11-03 Cadila Healthcare Limited Process for the purification of tissue plasminogen activator
WO2014202089A2 (en) 2013-06-18 2014-12-24 Roskilde Universitet Variants of anti-freeze polypeptides
CN107969127B (zh) 2015-09-08 2022-09-06 赛瑞品股份有限公司 Apoa-1融合多肽及相关组合物和方法
WO2018136163A2 (en) 2016-12-09 2018-07-26 Theripion, Inc. Tandem apoa-1 fusion polypeptides
JP2024507220A (ja) 2021-02-19 2024-02-16 セリピオン， インコーポレイテッド パラオキソナーゼ融合ポリペプチドならびに関連する組成物および方法
WO2024259220A1 (en) 2023-06-15 2024-12-19 Theripion, Inc. Pon3 and evolved pon1 fusion polypeptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171844A (en) * 1987-06-12 1992-12-15 Gist-Brocades N.W. Proteins with factor viii activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
US5037743A (en) * 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5326700A (en) * 1990-11-06 1994-07-05 Eli Lilly And Company DNA sequences encoding t-PA derivatives with cleavable sites
JPH06504438A (ja) * 1990-12-13 1994-05-26 イミュネックス・コーポレーション 白血病抑制因子受容体
AU4163196A (en) * 1994-11-30 1996-06-19 Zymogenetics Inc. Low molecular weight thrombopoietin

Also Published As

Publication number Publication date
EP0799317A1 (de) 1997-10-08
CN1171819A (zh) 1998-01-28
EP0799317B1 (de) 2004-04-28
EP0799317B8 (de) 2006-06-07
DE69532968D1 (de) 2004-06-03
WO1996017067A1 (en) 1996-06-06
AU689373B2 (en) 1998-03-26
AU4737696A (en) 1996-06-19
CA2206399A1 (en) 1996-06-06
KR100320106B1 (ko) 2002-02-19
ATE265538T1 (de) 2004-05-15
CA2206399C (en) 2001-02-20
NZ301858A (en) 1999-01-28
US5641655A (en) 1997-06-24
JP2002514887A (ja) 2002-05-21

Similar Documents

Publication Publication Date Title
DE69532968T2 (de) Verfahren zur sekretion thrombopoitin polypeptide
DE69332981D1 (de) Methoden zur herstellung löslicher, oligomerer proteine
UA27706C2 (uk) Спосіб одержання гетерологічного поліпептиду
ATE299942T1 (de) Verfahren zur herstellung von natürlich gefalteten proteinen durch co-sekretion von molekularen chaperonen
ATE80660T1 (de) Verfahren zur herstellung eines polypeptides.
ATE318917T1 (de) Verfahren zur bakteriellen herstellung von heterologen polypeptiden mit disulfidbrücke
ES8401133A1 (es) Metodo para preparar albumina de suero humano o una proteina de fusion de la misma.
CS9100241A2 (en) Method of composite proteins' enzymic splitting
AU3944002A (en) Metabolic rate shifts in fermentations expressing recombinant proteins
ATE408020T1 (de) Verfahren zur herstellung von faktor vii
AU8110487A (en) DNA molecules coding for proteins targeted to plant cell walls
IL133129A0 (en) Prenylcysteine carboxyl methyltransferase dna encoding same and a method of screening for inhibistors thereof
AR012499A1 (es) Una secuencia quimerica de acido nucleico que codifica una proteina de fusion, un vector de expresion que comprende dicha secuencia quimerica, una celula huesped transformada que contiene dicho vector, la proteina de fusion obtenida y un metodo in vitro para la preparacion de un polipeptido recombin
IL147456A0 (en) Production of proteins
DE69735242D1 (de) N-terminal verlängerte proteine exprimiert in hefe
DE3877035D1 (de) Gentechnologisches verfahren zur herstellung von polypeptiden.
DE69634757D1 (de) Vektor zur expression von n-terminal verlängerten proteinen in hefezellen
ATE196165T1 (de) Methoden zur herstellung von protein c
ATE131494T1 (de) Herstellung von fusionsproteinen oder - polypeptiden
DE3873273D1 (de) Verfahren zur selektiven spaltung von fusionsproteinen.
DK0422217T3 (da) Human, rekombinant, placental ribonucleaseinhibitor og fremgangsmåde til produktion
ES2170051T3 (es) Procedimiento para la produccion de proteinas utilizando proteinas fusionadas de tipo cks.
DK0575462T3 (da) Fremgangsmåde til fremstilling af chymosin
ATE207538T1 (de) Verfahren zur produktion von proteinen
AU2789000A (en) Sequences for improving the efficiency of secretion of non-secreted proteins from mammalian and insect cells

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee